Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Amortizatization of Intangibles: 2014-2024

Historic Amortizatization of Intangibles for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to $17.3 million.

  • Viking Therapeutics' Amortizatization of Intangibles fell 59.25% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 27.32%. This contributed to the annual value of $17.3 million for FY2024, which is 110.52% up from last year.
  • Per Viking Therapeutics' latest filing, its Amortizatization of Intangibles stood at $17.3 million for FY2024, which was up 110.52% from $8.2 million recorded in FY2023.
  • Viking Therapeutics' Amortizatization of Intangibles' 5-year high stood at $17.3 million during FY2024, with a 5-year trough of -$3.9 million in FY2021.
  • Over the past 3 years, Viking Therapeutics' median Amortizatization of Intangibles value was $8.2 million (recorded in 2023), while the average stood at $8.1 million.
  • As far as peak fluctuations go, Viking Therapeutics' Amortizatization of Intangibles tumbled by 202.57% in 2021, and later skyrocketed by 773.95% in 2023.
  • Viking Therapeutics' Amortizatization of Intangibles (Yearly) stood at $3.8 million in 2020, then tumbled by 202.57% to -$3.9 million in 2021, then surged by 68.84% to -$1.2 million in 2022, then surged by 773.95% to $8.2 million in 2023, then skyrocketed by 110.52% to $17.3 million in 2024.